# Shilpa Pharma Lifesciences Limited - Inspection Records

Source: https://www.keypedia.com/companies/shilpa-pharma-lifesciences-limited/4f617c67-eea7-483d-b9c7-b1dd31aabcff

> Inspection records and compliance data for Shilpa Pharma Lifesciences Limited in Raichur, KA. Access full analysis and detailed observations.

---

## Details

- Name: Shilpa Pharma Lifesciences Limited
- FEI Number: 3007197995
- City: Raichur
- State: KA
- Country Name: India
- Address Line 1: Unit 2
- Address Line 2: Plot No.33, 33A & 40 to 47, Raichur Industrial Growth Centre, Chicksugur
- Zip Code: 58413
- Facility Type: API Manufacturer
- Business Operations: API MANUFACTURE, API/FDF ANALYTICAL TESTING

## Related Documents

- [EIR - Shilpa Pharma Lifesciences Limited - 2025-03-14](https://www.keypedia.com/records/eir/shilpa-pharma-lifesciences-limited/036223cc-3567-4fdd-91cc-d7f0c3dddb4a) — source: FDA, date: March 14, 2025
- [FDA Inspection 1268017 - Shilpa Pharma Lifesciences Limited - 2025-03-14](https://www.keypedia.com/records/fda_inspections/shilpa-pharma-lifesciences-limited/099abeba-1941-43f2-a986-73c302c68f51) — source: FDA, date: March 14, 2025
- [FDA Inspection 1268017 - Shilpa Pharma Lifesciences Limited - 2025-03-14](https://www.keypedia.com/records/fda_inspections/shilpa-pharma-lifesciences-limited/c05f8235-07b2-49d6-ae5a-564fd3035628) — classification: No Action Indicated (NAI), source: FDA, date: March 14, 2025
- [FDA Inspection 1122653 - Shilpa Pharma Lifesciences Limited - 2020-02-07](https://www.keypedia.com/records/fda_inspections/shilpa-pharma-lifesciences-limited/c8b09e50-73f4-476a-af51-0ddec88ab6ed) — classification: No Action Indicated (NAI), source: FDA, date: February 7, 2020
- [483 - Shilpa Pharma Lifesciences Limited - 2019-07-26](https://www.keypedia.com/records/483/shilpa-pharma-lifesciences-limited/fd49f65b-bc3e-4b76-adc1-a8ef8ac6c192) — source: FDA, date: July 26, 2019
- [483 - Shilpa Pharma Lifesciences Limited - 2019-07-26](https://www.keypedia.com/records/483/shilpa-pharma-lifesciences-limited/bb6d959f-6c45-457b-8cdc-c587fe992235) — source: FDA, date: July 26, 2019
- [FDA Inspection 1099290 - Shilpa Pharma Lifesciences Limited - 2019-07-26](https://www.keypedia.com/records/fda_inspections/shilpa-pharma-lifesciences-limited/83adb497-fdf6-4c23-97c3-387b0f981a9a) — classification: Voluntary Action Indicated (VAI), source: FDA, date: July 26, 2019
- [483 - Shilpa Pharma Lifesciences Limited - 2018-01-19](https://www.keypedia.com/records/483/shilpa-pharma-lifesciences-limited/45380c3a-962d-4d61-a65a-9b306068fc0d) — source: FDA, date: January 19, 2018
- [FDA Inspection 1004337 - Shilpa Pharma Lifesciences Limited - 2016-12-16](https://www.keypedia.com/records/fda_inspections/shilpa-pharma-lifesciences-limited/5d720105-ac3e-4242-8ae2-84a3f0c57bb6) — classification: Voluntary Action Indicated (VAI), source: FDA, date: December 16, 2016
- [FDA Inspection 926998 - Shilpa Pharma Lifesciences Limited - 2015-03-09](https://www.keypedia.com/records/fda_inspections/shilpa-pharma-lifesciences-limited/bba52c5e-2ab9-4e24-a9b8-e8934bcf628b) — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 9, 2015
- [FDA Inspection 830428 - Shilpa Pharma Lifesciences Limited - 2013-05-03](https://www.keypedia.com/records/fda_inspections/shilpa-pharma-lifesciences-limited/3494d904-0572-42be-80d0-83dae2fc308d) — classification: Official Action Indicated (OAI), source: FDA, date: May 3, 2013

## Related Companies

- [Tianish Laboratories Private Limited](https://www.keypedia.com/companies/tianish-laboratories-private-limited/3aa20920-7f85-4cd2-806b-a3cfb4548be8)
- [MedImmune U.K. Limited](https://www.keypedia.com/companies/medimmune-uk-limited/fbddd1ed-5a0c-4c65-a48e-bb2af79482ed)
- [Tianish Laboratories Private Limited](https://www.keypedia.com/companies/tianish-laboratories-private-limited/e097960f-98b1-47f2-877c-d588005879b6)
- [Wyeth BioPharma Division of Wyeth Pharmaceuticals LLC](https://www.keypedia.com/companies/wyeth-biopharma-division-of-wyeth-pharmaceuticals-llc/0de9118f-18ec-45b8-b757-44f97c13c29c)
- [Aptuit (Oxford) Ltd.](https://www.keypedia.com/companies/aptuit-oxford-ltd/da0ef59c-f35f-478c-a844-0d223aa34b67)
- [PolyPeptide Laboratories Private Limited](https://www.keypedia.com/companies/polypeptide-laboratories-private-limited/bf5a7a5c-b537-4d71-87ce-a45650fd2b07)
- [Cipla Ltd.](https://www.keypedia.com/companies/cipla-ltd/d90a952b-3052-4e33-9969-5db3f2bbae82)
- [SpecGx LLC](https://www.keypedia.com/companies/specgx-llc/715bb75a-8d3a-4469-9e6d-f617c2f39c93)
- [Apitoria Pharma Private Limited](https://www.keypedia.com/companies/apitoria-pharma-private-limited/7a543877-97f7-4c4a-8dc8-74ee9d1c0caf)
- [Lonza AG](https://www.keypedia.com/companies/lonza-ag/7084f7e6-ce36-429f-942a-28e759416e70)

## Related Officers

- [June P. Page](https://www.keypedia.com/people/june-p-page/3b1ffc71-ce2e-47f5-aefe-87fd5eebc792)
- [Yvins Dezan](https://www.keypedia.com/people/yvins-dezan/e9fd12e6-c090-4eb6-bc78-8b80e8a90946)